Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
behavioural outcomes to in vivo PET imaging and molecular measures, the project aims to clarify the role of GPR6 in dopamine-related brain function and its potential as a therapeutic target for depression
-
1.1.2027 or as soon as possible. Job description You will be contributing to/establishing/developing an in-situ imaging system for NH3. You will be further developing optical NH3 sensors in the laboratory
-
take approaches combining mouse developmental genetics, cell-type-specific viral tracing, ex vivo electrophysiology, opto/chemogenetics, in vivo imaging, single-nucleus RNA sequencing (snRNA-seq), and
-
-resolution microscopy Genome editing (e.g., CRISPR-based approaches) Quantitative and live-cell imaging Functional genomics The project is embedded in an interdisciplinary research environment combining
-
against different operation conditions. The position is a part of a research project and prototype battery modules will be produced by one of the partners. The tasks include testing of these prototype
-
for downstream sequencing and imaging. Performing MALDI mass spectrometry and spatial transcriptomics to characterize biological niches within mouse and human tissue samples. Performing quantitative imaging
-
synchrotron or laboratory 3D diffraction imaging is considered as a significant advantage. Excellent English communication skills are also essential As a formal qualification, you must hold a PhD degree (or
-
significance of bioluminescence. We will also apply a range of advanced imaging techniques to visualize the light organs and their innervation. The successful applicant will be part of a highly interdisciplinary
-
modelling, or live neural imaging is desirable Experience working with neurons and knowledge in neurobiology is desirable Track record of international mobility is highly valued Publication record is
-
of radiotherapy, including proton therapy. This project will both aim at improving delineation and dose calculation in radiotherapy while reducing imaging dose and patient burden. The project will include